HIGH POWER (80 W) POTASSIUM-TITANYL-PHOSPHATE LASER VAPORIZATION OF THE PROSTATE IN 66 HIGH RISK PATIENTS

作者: OLIVER REICH , ALEXANDER BACHMANN , MICHAEL SIEBELS , ALFONS HOFSTETTER , CHRISTIAN G. STIEF

DOI: 10.1097/01.JU.0000146631.14200.D4

关键词:

摘要: ABSTRACTPurpose: Men with lower urinary tract symptoms secondary to benign prostatic hyperplasia who are at high cardiopulmonary risk or on oral anticoagulation often denied surgical treatment. Potassium-titanyl-phosphate (KTP) laser vaporization 80 W is a novel, rapidly emerging technique that promises instant hemostatic tissue ablation. We evaluated the merits of this procedure in patients and those long-term anticoagulation.Materials Methods: The prospective study included 66 severe underwent KTP prostate. All were risk, having presented an American Society Anesthesiology score 3 greater. Additionally, 29 being treated ongoing anticoagulant therapy (26) had bleeding disorder (3).Results: In all was performed successfully. Mean preoperative prostate volume ± SD 49 30 ml mean...

参考文章(19)
Bell, Murdock, Pasi, Morgan, Thrombotic risk factors associated with transurethral prostatectomy. BJUI. ,vol. 83, pp. 984- 989 ,(2001) , 10.1046/J.1464-410X.1999.00075.X
HARM H.E. van MELICK, GER E.P.M. van VENROOIJ, TOM A. BOON, Laser Prostatectomy in Patients on Anticoagulant Therapy or With Bleeding Disorders The Journal of Urology. ,vol. 170, pp. 1851- 1855 ,(2003) , 10.1097/01.JU.0000092502.56901.F7
PETER J. GILLING, KATIE KENNETT, AKHIL K. DAS, DAVID THOMPSON, MARK R. FRAUNDORFER, Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. Journal of Endourology. ,vol. 12, pp. 457- 459 ,(1998) , 10.1089/END.1998.12.457
Reza S. Malek, David M. Barrett, Randall S. Kuntzman, High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later Urology. ,vol. 51, pp. 254- 256 ,(1998) , 10.1016/S0090-4295(97)00613-4
Mesut Gürdal, Ali Tekin, Ergin Yücebaş, Feridun Şengör, Nd:YAG laser ablation plus transurethral resection for large prostates in high-risk patients. Urology. ,vol. 62, pp. 914- 917 ,(2003) , 10.1016/S0090-4295(03)00659-9
N. J. PARR, C. S. LOH, A. D. DESMONDOriginal Article, Transurethral Resection of the Prostate and Bladder Tumour without Withdrawal of Warfarin Therapy BJUI. ,vol. 64, pp. 623- 625 ,(1989) , 10.1111/J.1464-410X.1989.TB05322.X
OLIVER REICH, ALEXANDER BACHMANN, PETER SCHNEEDE, DIRK ZAAK, TULLIO SULSER, ALFONS HOFSTETTER, Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. The Journal of Urology. ,vol. 171, pp. 2502- 2504 ,(2004) , 10.1097/01.JU.0000128803.04158.76
A. J. COSTELLO, W. G. BOWSHER, D. M. BOLTON, K. G. BRASLIS, J. BURT, Laser ablation of the prostate in patients with benign prostatic hypertrophy. BJUI. ,vol. 69, pp. 603- 608 ,(1992) , 10.1111/J.1464-410X.1992.TB15631.X
Randall S. Kuntzman, Reza S. Malek, David M. Barrett, David G. Bostwick, Potassium-titanyl-phosphate laser vaporization of the prostate : A comparative functional and pathologic study in canines Urology. ,vol. 48, pp. 575- 583 ,(1996) , 10.1016/S0090-4295(96)00247-6